U.S. Court Ban On Federal Funding For Embryonic Stem Cell Research Would Help China In Race To Lead The Field
This article was originally published in PharmAsia News
Executive Summary
BEIJING - If a court battle now being waged in the American federal judiciary over embryonic stem cell research ends with a new ban on U.S. government funding for these studies, the freeze would give China a boost in its race to become a dominant power in this field, according to a scholar who tracks stem cell research on both sides of the Pacific